After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
DYN belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Dyne Therapeutics Inc is $1.38B. A total of 1.57 million shares were traded on the day, compared to an average of 1.73M shares.
In the most recent transaction, Beskrovnaya Oxana sold 2,598 shares of DYN for 13.95 per share on Feb 18 ’25. After the transaction, the Chief Scientific Officer now owns 199,087 company shares. In a previous transaction on Feb 18 ’25, Scalzo Richard William sold 2,488 shares at 13.95 per share. DYN shares that SVP, Head of Finance & Admin. owns now total 124,590.
Among the insiders who bought shares, Scalzo Richard William acquired of 2,488 shares on Feb 18 ’25 at a per-share price of $13.91. In another insider transaction, Beskrovnaya Oxana bought 2,598 shares at $13.91 per share on Feb 18 ’25.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, DYN has a high of $47.45 and a low of $13.07.
As of this writing, DYN has an earnings estimate of -$0.91 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of -$0.67 per share and a lower estimate of -$1.23.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. DYN’s latest balance sheet shows that the firm has $376.57M in Cash & Short Term Investments as of fiscal 2021. There were $32.64M in debt and $28.72M in liabilities at the time. Its Book Value Per Share was $6.93, while its Total Shareholder’s Equity was $368.20M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DYN is Buy with a score of 4.75.
